DrugPatentWatch Database Preview
Lundbeck Seattle Biopharmaceuticals, Inc Company Profile
» See Plans and Pricing
US Patents for Lundbeck Seattle Biopharmaceuticals, Inc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lundbeck Seattle Biopharmaceuticals, Inc. | VYEPTI | eptinezumab-jjmr | INJECTABLE;INJECTION | 761119 | 001 | 2020-02-21 | RX | |||||
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
This search can help find similar names.